Ace Your 2025 Pharmacy CE Exam – Boost Your Knowledge and Elevate Your Skills!

Question: 1 / 400

Which statement about the prevalence of FOP is TRUE?

It is common, affecting 1 in 100,000 people

It is ultra-rare, affecting approximately 1 in 2 million people

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by the abnormal development of bone in muscles, tendons, and other connective tissues. The prevalence of FOP is notably low, estimated to affect approximately 1 in 1,500,000 to 1 in 2,000,000 people, which aligns with the statement that classifies it as ultra-rare. This rarity is a key factor that healthcare professionals need to understand when encountering cases that may present symptoms suggestive of FOP.

The statistics highlighting its ultra-rare status emphasize the need for increased awareness and knowledge among healthcare providers since such conditions often lead to misdiagnosis or a lack of proper management due to their obscurity. In contrast, the other statements are misleading as they either overstate the prevalence or imply a level of understanding and available diagnostic criteria that do not reflect the true nature of FOP, which can be complex and challenging to diagnose.

Get further explanation with Examzify DeepDiveBeta

It has many common diagnostic criteria available

It is a well-understood condition among healthcare providers

Next Question

Report this question

Download Pharmacy Continuing Education (CE) Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy